Molecular Diagnostics
Novel Autoantibody against Septin-3 Discovered in Neurological Disease
Septin-5 and septin-7 are already known target antigens of autoantibodies in neurological diseases. Now, scientists have discovered autoantibodies against septin-3 in patients with paraneoplastic cerebellar ataxia. More...27 Apr 2023
MDx Platform Offers Largest Variety of Leukemia-Related Diagnostic Tests for Early Detection
A new molecular leukemia diagnostic platform offers 12 molecular diagnostic tests specialized in leukemia early diagnosis, treatment guidance and MRD (Minimal residual disease) monitoring. More...26 Apr 2023


Blood Tests Can Help Physicians Correctly Diagnose Alzheimer's In Low-Resource Environments
Neurologists are investigating a combination of blood tests and memory assessments to enhance the diagnostic accuracy of Alzheimer's disease in low-resource communities, which are home to 58% of the global dementia population. More...25 Apr 2023

Portable UTI Testing Platform Brings Lab-Quality Molecular Diagnostics to Point-Of-Care Settings
Llusern Scientific is launching its UTI assay panel which can test for up to six urinary tract infections (UTIs) at the point-of-care, revolutionizing the way clinicians test for UTIs. More...25 Apr 2023


Multi-Cancer Blood Test Leverages Machine Learning to Detect and Classify Underlying Disease
A cutting-edge genome-wide methylome enrichment platform has the potential to detect early-stage diseases, thanks to the breadth of information captured through the whole methylome approach. More...21 Apr 2023
In Other News
First-Ever Mpox Rapid Test Can Be Adapted for Other Emerging Diseases
Minimally Invasive Blood Test Detects Breast Cancer at Earlier Stages
Rapid Molecular Diagnostics Platform Uses Multiplex PCR Technology for Fast Diagnosis of Severe Infectious Diseases
Rapid Metagenomics Diagnoses Antibiotic Resistant Bloodstream Infections 18-42 Hours Faster Than Conventional Tests
30-Minute Molecular Assay to Revolutionize Tuberculosis Diagnosis within Near Patient Settings
Novel Reference Materials Meet Needs of Labs Testing for BRCA1/2 Gene Variants
Revolutionary Tests Powered by Exosome-Isolation Technology to Detect Challenging Cancers from Blood Draw
Nanopore-Based Molecular Sensing Technology to Advance Infectious Disease Diagnostics
Clinical RNA Sequencing Platform Can Improve Rare Disease Diagnostics in Pediatrics
Electrochemical Sensor Detects Early-Stage Parkinson’s in Blood Samples
Next Generation Cardiac Control Monitors Precision of Instrument Testing For Cardiac Events
Gastrointestinal PCR Assay Offers Rapid, Culture-Free Pathogen Identification
Novel Testing Method Detects HIV and Hepatitis B/C from Single Drop of Blood
Simple ALS Diagnostic Blood Test Delivers Robust and Reproducible Results
Blood Test Can Predict How Patient’s Cancer Could Grow and Spread
Biological Test Could Be a Game-Changer in Parkinson’s Diagnostics
First and Only Clinically Validated Circulating TTMV DNA Blood Test Detects HPV-Driven Cancer
First-of-Its-Kind Study Establishes Pediatric Reference Intervals for Common Cardiovascular Disease Tests
World’s Most Comprehensive Whole Genome Sequencing Solution Diagnoses Rare and Neurodegenerative Diseases
Blood Test to Measure Sugar Molecule Can Predict Alzheimer’s
Genomic Testing to Help Better Assess and Treat Heart Disease Patients
Next-Generation Diagnostic Test Predicts Drug Responses to Enable More Precise Cancer Therapy
Pocket Laboratory Offers Fast and Reliable Diagnosis at Point of Care
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







